Construction and In Vitro and In Vivo Analysis of Coxsackievirus B4 Reporter Viruses: Attenuated Virulence but Highly Efficient for Antiviral Drug Screening and Evaluation
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Qian Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, Chi…. Hauptthemen laut MEDLINE: Enterovirus B, Human, Antiviral Agents, Genes, Reporter. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (81970003), National Key Research and Development Program (2023YFC3040600), and th….
Abstract (Originalsprache)
Coxsackievirus B4 (CVB4) is an enterovirus with one of the highest mortality rates following infection, yet research on it remains limited. To enhance the efficiency of CVB4 research, we developed the rCVB4‐EGFP and rCVB4‐NanoLuc reporter viruses. The replication kinetics of these reporter viruses in SH‐SY5Y and HeLa cells were essentially consistent with those of the wild‐type CVB4. A strong correlation was observed between the fluorescence and bioluminescence signals of rCVB4‐EGFP and rCVB4‐NanoLuc and viral titers at specific times postinfection. When evaluating the anti‐CVB4 drug fluoxetine using these reporter viruses, the half‐maximal effective concentrations derived from fluorescence signals, bioluminescence signal intensities, and viral genome copies were consistent. In In Vivo drug evaluations, because CVB4 can infect various tissues and organs, the bioluminescence signal of rCVB4‐NanoLuc effectively demonstrated the antiviral effects of drugs, offering significant advantages over traditional tissue viral titer analysis. The reporter viruses exhibited reduced virulence compared with wild‐type CVB4 both In Vitro, in SH‐SY5Y and HeLa cells, and In Vivo, in ICR suckling mice. Although this reduced virulence may limit their application for studying pathogenic mechanisms, these reporter viruses can serve as highly efficient tools for high‐throughput screening and evaluation of anti‐CVB4 drugs, vaccines, and neutralizing antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
- State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital…
- Guangzhou Laboratory, Bio-Island, Guangzhou, China.
ORCID-Profile: Rong Zhou, Wenkuan Liu
Förderung
- This study was supported by the National Natural Science Foundation of China (81970003), National Key Research and Development Program (2023YFC3040600), and th…
Zitieren
APA
Liu, Q., Wang, H., Xuan, X., Liu, H., Tang, B., Zhou, Z., Zhang, L., Qiu, S., Li, X., Tian, X., Zhou, R., & Liu, W. (2025). Construction and In Vitro and In Vivo Analysis of Coxsackievirus B4 Reporter Viruses: Attenuated Virulence but Highly Efficient for Antiviral Drug Screening and Evaluation. Journal of Medical Virology. https://doi.org/10.1002/jmv.70433
Vancouver
Liu Q, Wang H, Xuan X, Liu H, Tang B, Zhou Z, et al. Construction and In Vitro and In Vivo Analysis of Coxsackievirus B4 Reporter Viruses: Attenuated Virulence but Highly Efficient for Antiviral Drug Screening and Evaluation. Journal of Medical Virology. 2025. doi:10.1002/jmv.70433
BibTeX
@article{Liu2025,
author = {Liu, Qian and Wang, Huan and Xuan, Xianglin and Liu, Haoyi and Tang, Bizhen and Zhou, Zhichao and Zhang, Li and Qiu, Shuyan and Li, Xiao and Tian, Xingui and Zhou, Rong and Liu, Wenkuan},
title = {Construction and In Vitro and In Vivo Analysis of Coxsackievirus B4 Reporter Viruses: Attenuated Virulence but Highly Efficient for Antiviral Drug Screening and Evaluation},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70433}
}
EUVIMED